“Effective vaccination will be key to managing #COVID19 in the long-term, but we’ll need more than one safe and effective vaccine to achieve this goal” - Nick Jackson on ’ COVID-19 vaccine portfolio
“Most vaccine candidates in early development fail: this is the stark reality of vaccine development” - ’ Nick Jackson. Read more about why active portfolio management is key to vaccine research and development
“Most vaccine candidates in early development fail: this is the stark reality of vaccine development” - interesting insights from Nick Jackson on why #COVAX has the world’s largest and most diverse portfolio of #COVID19 vaccines
Why we need a “portfolio approach” to COVID-19 vaccine development via